ASCO GU 2021: Retroperitoneal Lymph Node Dissection Should Be Considered First-Line for Metastatic Seminoma
Few short-term and no long-term complications were reported in the SEMS trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.